| Travis Eugene Denny, DO | |
|
647 North Broad Street Extention, Suite 106, Grove City, PA 16127-4604 | |
| (724) 458-8460 | |
| (724) 458-5062 |
| Full Name | Travis Eugene Denny |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 647 North Broad Street Extention, Grove City, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386263507 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS023141 (Pennsylvania) | Primary |
| Entity Name | Allegheny Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073081493 PECOS PAC ID: 5395649586 Enrollment ID: O20040310000602 |
News Archive
Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and obtained the Certificate for the Release of Biological Products, which means the released vaccines are ready for delivery.
Nerve cells in the skin help wounds to heal. When an injury occurs, cells known as glial cells change into repair cells and disseminate into the wound, where they help the skin to regenerate, researchers from the University of Zurich have shown.
When chemists want to produce a lot of a substance - such as a newly designed drug - they often turn to catalysts, molecules that speed chemical reactions. Many jobs require highly specialized catalysts, and finding one in just the right shape to connect with certain molecules can be difficult. Natural catalysts, such as enzymes in the human body that help us digest food, get around this problem by shape-shifting to suit the task at hand.
A new study systematically reviews vaccine efficacy and vaccine effectiveness (VE) of COVID-19 vaccines.
Results from the largest prospective controlled ulcerative colitis (UC) trial conducted to date, called the QD dosing investigation for efficacy IN UC maintenance (QDIEM), found that once-daily dosing of Asacol(R) (mesalamine) delayed-release 400 mg tablets at 1.6-2.4 g/day was comparable to twice-daily dosing for the maintenance of remission in patients with UC.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Travis Eugene Denny, DO 647 North Broad Street Extention, Suite 106, Grove City, PA 16127-4604 Ph: (724) 458-8460 | Travis Eugene Denny, DO 647 North Broad Street Extention, Suite 106, Grove City, PA 16127-4604 Ph: (724) 458-8460 |
News Archive
Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading provider of vaccines in China, today announced that the first lot of PANFLU.1, its H1N1 vaccine, has passed the lot release process of China's National Institute for the Control of Pharmaceutical and Biological Products and obtained the Certificate for the Release of Biological Products, which means the released vaccines are ready for delivery.
Nerve cells in the skin help wounds to heal. When an injury occurs, cells known as glial cells change into repair cells and disseminate into the wound, where they help the skin to regenerate, researchers from the University of Zurich have shown.
When chemists want to produce a lot of a substance - such as a newly designed drug - they often turn to catalysts, molecules that speed chemical reactions. Many jobs require highly specialized catalysts, and finding one in just the right shape to connect with certain molecules can be difficult. Natural catalysts, such as enzymes in the human body that help us digest food, get around this problem by shape-shifting to suit the task at hand.
A new study systematically reviews vaccine efficacy and vaccine effectiveness (VE) of COVID-19 vaccines.
Results from the largest prospective controlled ulcerative colitis (UC) trial conducted to date, called the QD dosing investigation for efficacy IN UC maintenance (QDIEM), found that once-daily dosing of Asacol(R) (mesalamine) delayed-release 400 mg tablets at 1.6-2.4 g/day was comparable to twice-daily dosing for the maintenance of remission in patients with UC.
› Verified 2 days ago
Charles H Grande, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1440 Carrie Way, Grove City, PA 16127 Phone: 724-458-5976 | |
Dr. Shubhada Sawardekar, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 201c Erie St, Grove City, PA 16127 Phone: 724-458-7005 Fax: 724-458-5297 | |
Jared Matthew Ramsey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 647 N Broad Street Ext Ste 107, Grove City, PA 16127 Phone: 724-458-8460 Fax: 724-458-5062 | |
Edward Smith, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 Hillcrest Ave, Grove City, PA 16127 Phone: 724-458-4950 | |
Kevin A Thomas, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 675 N Broad Street Ext, Suite 4, Grove City, PA 16127 Phone: 724-458-8754 Fax: 724-662-2782 | |
Christopher Sprando, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 420 Hillcrest Ave, Grove City, PA 16127 Phone: 724-458-4950 |